
Promising Male Birth Control Gel Proves Safe and Effective in Trials
A combination hormonal topical gel for male birth control has shown promise in early-stage clinical trials by effectively suppressing sperm production in a shorter time frame. The Phase 2b trial, involving 222 men, demonstrated that 86% of participants achieved the desired low sperm count by Week 15. The gel, developed by the Population Council and the National Institutes of Health, offers a potential new contraceptive method for men, marking a significant milestone in reproductive health.


